S 4390 · 117th Congress
Accelerated Approval Transparency Act
<p><b>Accelerated Approval Transparency Act</b></p> <p>This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic. </p>
- Sponsor
- Hickenlooper, John W. (D-CO)
- Introduced
- 2022-06-14
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍